Insulin pump therapy (continuous subcutaneous insulin infusion)
Related Experiment Video
Updated: Jul 9, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
1Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center Lakewood, Kansas City, MO 64139, USA. Russell.White@tmcmed.org
Abstract:
Continuous subcutaneous insulin infusion has provided patients who have diabetes with a system for achieving treatment targets with a lower incidence of severe hypoglycemia. Patients prefer the flexibility, convenience, and physiologic glycemic control of continuous subcutaneous insulin infusion. Future insulin pumps will be implanted within the body and the "loop" will be closed, providing a physiologic insulin delivery system. This system will provide the means for achieving near-normal glycemia, limit episodes of severe hypoglycemia, and prevent long-term complications of diabetes mellitus.
Related Concept Videos
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous Renal Replacement Therapy
